101 related articles for article (PubMed ID: 28747604)
1. [Methotrexate-associated lymphoproliferative disorder].
Kaneko Y
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):174-178. PubMed ID: 28747604
[TBL] [Abstract][Full Text] [Related]
2. Polymorphic lymphoproliferative disorder arising in a rheumatoid arthritis patient, presenting as fibrin-associated large B-cell lymphoma-like lesions in aortic and mitral valves.
Tsujii H; Nakayama R; Funakoshi S; Tsuji S; Haga H; Ono K
Pathol Int; 2024 May; 74(5):285-291. PubMed ID: 38563592
[TBL] [Abstract][Full Text] [Related]
3. Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis.
Tanaka K; Ichikawa A; Umezawa N; Yamamoto K; Yoshifuji K; Okada K; Nogami A; Umezawa Y; Nagao T; Sakashita C; Mori T; Tohda S; Koike R; Yasuda S; Yamamoto M
Cancer Sci; 2023 Sep; 114(9):3719-3727. PubMed ID: 37365854
[TBL] [Abstract][Full Text] [Related]
4. Effect of Recent Antirheumatic Drug on Features of Rheumatoid Arthritis-Associated Lymphoproliferative Disorders.
Hoshida Y; Tsujii A; Ohshima S; Saeki Y; Yagita M; Miyamura T; Katayama M; Kawasaki T; Hiramatsu Y; Oshima H; Murayama T; Higa S; Kuraoka K; Hirano F; Ichikawa K; Kurosawa M; Suzuki H; Chiba N; Sugiyama T; Minami Y; Niino H; Ihata A; Saito I; Mitsuo A; Maejima T; Kawashima A; Tsutani H; Takahi K; Kasai T; Shinno Y; Tachiyama Y; Teramoto N; Taguchi K; Naito S; Yoshizawa S; Ito M; Suenaga Y; Mori S; Nagakura S; Yoshikawa N; Nomoto M; Ueda A; Nagaoka S; Tsuura Y; Setoguchi K; Sugii S; Abe A; Sugaya T; Sugahara H; Fujita S; Kunugiza Y; Iizuka N; Yoshihara R; Yabe H; Fujisaki T; Morii E; Takeshita M; Sato M; Saito K; Matsui K; Tomita Y; Furukawa H; Tohma S
Arthritis Rheumatol; 2024 Jun; 76(6):869-881. PubMed ID: 38272827
[TBL] [Abstract][Full Text] [Related]
5. Central Nervous System Lymphoproliferative Disorder Secondary to Methotrexate: A Systematic Literature Review and Case Illustration.
In A; Stopa BM; Cuoco JA; Stump MS; Apfel LS; Rogers CM
World Neurosurg; 2023 Nov; 179():118-126. PubMed ID: 37574195
[TBL] [Abstract][Full Text] [Related]
6. Macrophage activation syndrome triggered by methotrexate-related lymphoproliferative disease in a patient with rheumatoid arthritis.
Kato H; Suzuki M; Misumi K; Kohsaka H
Immunol Med; 2023 Dec; 46(4):191-195. PubMed ID: 37199221
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate-associated lymphoproliferative disorder in the thyroid gland of a patient with chronic thyroiditis.
Hiruma M; Tsuboi K; Hirose T
J Med Ultrason (2001); 2023 Oct; 50(4):575-576. PubMed ID: 37526779
[No Abstract] [Full Text] [Related]
8. Hepatic and lung methotrexate-associated polymorphic lymphoproliferative disorders arising during postoperative follow-up of renal cell carcinoma: a case report.
Miyamoto Y; Kawasoe C; Ito K; Oguri N; Murashima T; Kamibeppu T; Nagai T; Takamori H; Kamimura T; Mukai S; Sato Y; Kamoto T
J Med Case Rep; 2023 Dec; 17(1):524. PubMed ID: 38129899
[TBL] [Abstract][Full Text] [Related]
9. Regression of Necrotic Lesions after Methotrexate Withdrawal in Patients with Methotrexate-Associated Lymphoproliferative Disorders: A Retrospective CT Study.
Kitayama T; Tanaka T; Kanie Y; Marukawa Y; Kojima K; Tanaka T; Takao S; Hiraki T
Acta Med Okayama; 2024 Feb; 78(1):29-36. PubMed ID: 38419312
[TBL] [Abstract][Full Text] [Related]
10. Clinical Images: Epistaxis may be a warning sign of lymphoproliferative disorder during methotrexate treatment for dermatomyositis.
Ishigaki S; Kajio N; Okayama M; Orikasa H; Tanaka S; Yoshikawa N; Taguchi H
ACR Open Rheumatol; 2024 Mar; 6(3):123. PubMed ID: 38117905
[No Abstract] [Full Text] [Related]
11. Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: A review of the literature and current perspective.
Harigai M
Mod Rheumatol; 2018 Jan; 28(1):1-8. PubMed ID: 28758827
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic investigation of methotrexate-induced lymphoproliferative disorders, with a focus on regression.
Tokuhira M; Saito S; Okuyama A; Suzuki K; Higashi M; Momose S; Shimizu T; Mori T; Anan-Nemoto T; Amano K; Okamoto S; Takeuchi T; Tamaru JI; Kizaki M
Leuk Lymphoma; 2018 May; 59(5):1143-1152. PubMed ID: 28877615
[TBL] [Abstract][Full Text] [Related]
13. [Safety and effectiveness of certolizumab pegol in patients with rheumatoid arthritis: Interim analysis of post-marketing surveillance].
Kameda H; Nishida K; Nannki T; Watanabe A; Oshima Y; Momohara S
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):196-205. PubMed ID: 28747607
[TBL] [Abstract][Full Text] [Related]
14. A systemic review and meta-analysis of the clinical efficacy and safety of total glucosides of peony combined with methotrexate in rheumatoid arthritis.
Feng ZT; Xu J; He GC; Cai SJ; Li J; Mei ZG
Clin Rheumatol; 2018 Jan; 37(1):35-42. PubMed ID: 28748514
[TBL] [Abstract][Full Text] [Related]
15. Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders.
Tokuhira M; Tamaru JI; Kizaki M
J Clin Exp Hematop; 2019; 59(2):72-92. PubMed ID: 31257348
[TBL] [Abstract][Full Text] [Related]
16. Non-persistence and non-adherence to MTX therapy in patients with rheumatoid arthritis: a retrospective cohort study based on German RA patients.
Müller S; Wilke T; Fuchs A; Maywald U; Flacke JP; Heinisch H; Krüger K
Patient Prefer Adherence; 2017; 11():1253-1264. PubMed ID: 28790807
[TBL] [Abstract][Full Text] [Related]
17. Immune response in LPD during methotrexate administration (MTX-LPD) in rheumatoid arthritis patients.
Saito S; Takeuchi T
J Clin Exp Hematop; 2019; 59(4):145-155. PubMed ID: 31866617
[TBL] [Abstract][Full Text] [Related]
18. [Methotrexate-associated lymphoproliferative disorders: clinical aspects].
Tokuhira M; Kizaki M
Rinsho Ketsueki; 2019; 60(8):932-943. PubMed ID: 31484893
[TBL] [Abstract][Full Text] [Related]
19. Etanercept (Enbrel
Shannon E; Daffy J; Jones H; Paulson A; Vicik SM
Clin Pharmacol; 2017; 9():87-99. PubMed ID: 28790869
[TBL] [Abstract][Full Text] [Related]
20. Interleukin (IL-6) Immunotherapy.
Tanaka T; Narazaki M; Kishimoto T
Cold Spring Harb Perspect Biol; 2018 Aug; 10(8):. PubMed ID: 28778870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]